Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Sequent Scientific is currently trading at Rs. 83.79, up by 9.42 points or 12.67% from its previous closing of Rs. 74.37 on the BSE.
The scrip opened at Rs. 75.31 and has touched a high and low of Rs. 84.40 and Rs. 75.31 respectively. So far 1353896 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 155.90 on 06-Apr-2022 and a 52 week low of Rs. 61.80 on 08-Mar-2023.
Last one week high and low of the scrip stood at Rs. 84.40 and Rs. 61.80 respectively. The current market cap of the company is Rs. 2083.77 crore.
The promoters holding in the company stood at 52.79%, while Institutions and Non-Institutions held 9.06% and 38.15% respectively.
Sequent Scientific has terminated Share Purchase Agreement with Tineta Pharma (Tineta) and its Promoters, regarding acquisition of 100% stake in Tineta by the Company. The transaction contemplated under the Share Purchase Agreement has not been materialized. Therefore, the Company will not acquire Tineta.
Earlier, Sequent Scientific had received an approval for acquisition of 100% stake in Tineta Pharma from its existing shareholders for a consideration to be discharged partly by cash and partly by issuance of equity shares of the Company through preferential allotment route.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1462.50 |
| Dr. Reddys Lab | 5784.50 |
| Cipla | 1451.25 |
| Zydus Lifesciences | 1001.15 |
| Lupin | 1587.90 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
